Option Care Health (NASDAQ:OPCH) Releases Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.42-0.45 for the period, compared to the consensus estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY25 guidance to $1.59-1.69 EPS.

Option Care Health Stock Down 0.6 %

Shares of OPCH opened at $23.99 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 20.16, a PEG ratio of 2.43 and a beta of 1.31. The stock has a fifty day moving average of $23.10 and a 200-day moving average of $27.69.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. Barrington Research reduced their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Truist Financial decreased their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health presently has an average rating of “Hold” and a consensus target price of $29.14.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.